A detailed history of Burgundy Asset Management Ltd. transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Burgundy Asset Management Ltd. holds 1,304 shares of CRL stock, worth $255,284. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,304
Previous 1,073 21.53%
Holding current value
$255,284
Previous $221,000 15.84%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$187.96 - $245.29 $43,418 - $56,661
231 Added 21.53%
1,304 $256,000
Q4 2023

Feb 13, 2024

BUY
$164.52 - $238.84 $176,529 - $256,275
1,073 New
1,073 $253,000

Others Institutions Holding CRL

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.


  • Ticker CRL
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 50,863,300
  • Market Cap $9.96B
  • Description
  • Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...
More about CRL
Track This Portfolio

Track Burgundy Asset Management Ltd. Portfolio

Follow Burgundy Asset Management Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Burgundy Asset Management Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Burgundy Asset Management Ltd. with notifications on news.